Michael Young
Chairman at BETTER CHOICE COMPANY INC.
Net worth: 359 623 $ as of 2024-04-29
Profile
Mr. Michael M.
Young is a Chairman at Better Choice Co., Inc. and a Managing Director at Cottingham Capital Ltd.
He is on the Board of Directors at Apolo IV Acquisition Corp.
Mr. Young was previously employed as a Chief Technology Officer by Thomson Reuters Corp., an Independent Director by ICC Labs, Inc., a Managing Director by GMP Capital Corp., a Managing Director by GMP Capital, Inc. /CA/, a Director-Institutional Trading by GMP Securities LP, a Managing Director by Griffiths McBurney Corp., a Chairman by Origin Therapeutics Holdings, Inc., and a Non-Executive Independent Director by Yooma Wellness, Inc. He also served on the board at Vice Health & Wellness, Inc., Apolo II Acquisition Corp., Eve & Co., Inc., XIB I Capital Corp., Aphria International, Inc. and Nuuvera Holdings Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-10 | 52,865 ( 5.92% ) | 343 623 $ | 2024-04-29 | |
| 2023-05-08 | 500,000 ( 6.67% ) | 16 000 $ | 2024-04-29 |
Michael Young active positions
| Companies | Position | Start |
|---|---|---|
| BETTER CHOICE COMPANY INC. | Chairman | 2020-01-08 |
| APOLO IV ACQUISITION CORP. | Director/Board Member | 2021-01-19 |
| Cottingham Capital Ltd. | Founder | 2016-12-31 |
Former positions of Michael Young
| Companies | Position | End |
|---|---|---|
| SAFE SUPPLY STREAMING CO. LTD. | Chairman | 2022-10-02 |
| YOOMA WELLNESS INC. | Director/Board Member | 2021-04-27 |
| ICC LABS INC | Director/Board Member | 2018-11-30 |
| EVE & CO INCORPORATED | Director/Board Member | 2018-09-30 |
Aphria International, Inc.
 Aphria International, Inc. Pharmaceuticals: MajorHealth Technology Aphria International, Inc. engages in the development and production of medical cannabis products. It operates with partners in Germany, Israel and Italy, and is exploring opportunities in several other countries, to develop commercial production and global distribution of medical grade cannabis in legalized markets. The company is headquartered in Brampton, Canada. | Director/Board Member | 2018-04-30 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 7 |
|---|---|
| EVE & CO INCORPORATED | Health Technology |
| RF CAPITAL GROUP INC. | Finance |
| BETTER CHOICE COMPANY INC. | Retail Trade |
| THOMSON REUTERS CORPORATION | Technology Services |
| VICE HEALTH AND WELLNESS INC. | Distribution Services |
| APOLO IV ACQUISITION CORP. | Finance |
| YOOMA WELLNESS INC. | Distribution Services |
| Private companies | 10 |
|---|---|
GMP Securities LP
 GMP Securities LP Investment Banks/BrokersFinance Founded in 1995, GMP Securities LP is broker/dealer headquartered in Toronto with additional offices in Calgary and Montreal. The firm is a subsidiary of GMP Capital, Inc. (GMP: Toronto). They offer institutional sales, research, trading, investment banking and underwriting and advisory services. GMP Securities primarily focuses on the biotechnology, technology, mining, oil and gas, oil and gas income trusts, industrials, special situations and non-bank financial services sectors. | Finance |
Griffiths McBurney Corp.
 Griffiths McBurney Corp. Investment Banks/BrokersFinance Founded in 1995, Griffiths McBurney Corp. is a broker/dealer headquartered in Toronto, Ontario. The firm is a subsidiary of GMP Capital, Inc. (GMP: Toronto). They provide a full array of trading and execution services. Griffiths McBurney Corp. does not provide any internal research. All research is conducted through GMP Securities. | Finance |
ICC Labs, Inc.
 ICC Labs, Inc. Agricultural Commodities/MillingProcess Industries ICC Labs, Inc. produces, develops and vendors recreational cannabis, medicinal cannabis and industrial hemp. It offers Agribusiness, Agroindustry, Cannabis, Hemp, CBD, Therpens, Cannabinoids, Hemp Oil, Hemp Fibre and Hemp Products. The company was founded in 2014 and is headquartered in Vancouver, Canada. | Process Industries |
| Cottingham Capital Ltd. | |
Aphria International, Inc.
Aphria International, Inc. Pharmaceuticals: MajorHealth Technology Aphria International, Inc. engages in the development and production of medical cannabis products. It operates with partners in Germany, Israel and Italy, and is exploring opportunities in several other countries, to develop commercial production and global distribution of medical grade cannabis in legalized markets. The company is headquartered in Brampton, Canada. | Health Technology |
| GMP Capital Corp. | Miscellaneous |
XIB I Capital Corp.
 XIB I Capital Corp. Financial ConglomeratesFinance XIB I Capital Corp. engages in identification and evaluation of assets or businesses with a view to completing a Qualifying Transaction. The company was founded on March 8, 2018 and is headquartered in Vancouver, Canada. | Finance |
Apolo II Acquisition Corp.
 Apolo II Acquisition Corp. Financial ConglomeratesFinance Apolo II Acquisition Corp. is a capital pool company. It intends to identify and evaluate businesses or assets with a view to completing a qualifying transaction. The company was founded on December 15, 2017 and is headquartered in Toronto, Canada. | Finance |
Nuuvera Holdings Ltd.
 Nuuvera Holdings Ltd. Medical DistributorsDistribution Services Nuuvera Holdings Ltd. wholesales drugs. The firm focuses on building a global, chemical fee, pesticide free, vertically integrated business with an emphasis on principal elements: research & development of plant genetics, developing and maintaining proprietary control over plant genetics, cultivation of plant genetics, processing of harvested plant materials and marketing, sales & distribution. The company is headquartered in Toronto, Canada. | Distribution Services |
Origin Therapeutics Holdings, Inc.
 Origin Therapeutics Holdings, Inc. Financial ConglomeratesFinance Origin Therapeutics Holdings, Inc. engages in the provision of investment services for psychedelic industry. It also plans to invest in opportunities involving, where legally permitted, the research, design, development, testing, production, distribution, and sale of psychedelics and services. The company was founded on December 9, 2020 and is headquartered in Vancouver, Canada. | Finance |
- Stock Market
- Insiders
- Michael Young
